Kolexia
Resbeut Michel Radio-thérapie
Resbeut Michel
Radio-thérapie
Centre Paoli-Calmettes
Marseille, France
54 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Récidive tumorale locale Carcinomes Métastase lymphatique Tumeurs de l'anus Carcinome épidermoïde Tumeurs du rectum Métastase tumorale Carcinome canalaire du sein

Collaborateurs

Voir plus
Richard Tallet Agnes
Richard Tallet Agnes
Centre Paoli-Calmettes, Marseille, France
Houvenaeghel Gilles
Houvenaeghel Gilles
Centre Paoli-Calmettes, Marseille, France
Moureau-Zabotto Laurence
Moureau-Zabotto Laurence
Centre Paoli-Calmettes, Marseille, France
Cowen Didier
Cowen Didier
Clinique Chirurgicale De Martigues, Martigues, France

Industries

Voir plus
Janssen
3 collaboration(s)
Dernière en 2016
Amgen
1 collaboration(s)
Dernière en 2016
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Multivariate normal tissue complication probability modeling of vaginal late toxicity after brachytherapy for cervical cancer.
Brachytherapy   27 juillet 2018
Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy.
Journal of applied clinical medical physics   30 juin 2018
Prostate Hypofractionated Radiation Therapy With a Rectal Spacer Comparing Moderate Hypofractionation (62 Gy at 3.1 Gy per Fraction) Versus Stereotactic Irradiation (37.5 Gy at 7.5 Gy per Fraction): Acute Toxicities from the RPAH2 Randomized Trial
Proceedings of the American Society for Radiation Oncology 2017   01 octobre 2017
Survival after breast cancer local recurrence according to therapeutic strategies.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   04 mai 2017
Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience.
Bulletin du cancer   16 février 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Bone marrow transplantation   16 janvier 2017
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.
BMC surgery   15 novembre 2016
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.
Journal of Cancer   23 octobre 2016
Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" Eur J Cancer 57 (April 2016) 118-126.
European journal of cancer (Oxford, England : 1990)   24 septembre 2016
Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.
World journal of clinical oncology   15 avril 2016